Qualisure Diagnostics
Qualisure Diagnostics Inc. is a precision oncology company that develops molecular diagnostic tests to personalize cancer care by identifying unique tumor molecular signatures. Their flagship product, Thyroid GuidePx®, is a genomic classifier that stratifies papillary thyroid cancer into molecular subtypes to guide treatment decisions and predict recurrence risk. The company leverages machine learning and genomic data to create clinically actionable tests that help oncologists select appropriate treatments, improving patient outcomes and reducing unnecessary toxic therapies. Qualisure's approach is backed by over 25 years of research and clinical experience, with a focus on innovation, patient-centered care, and collaboration. Their tests are designed to be accessible and scalable, supporting precision medicine as a standard of care in oncology.
Qualisure Diagnostics
Qualisure Diagnostics Inc. is a precision oncology company that develops molecular diagnostic tests to personalize cancer care by identifying unique tumor molecular signatures. Their flagship product, Thyroid GuidePx®, is a genomic classifier that stratifies papillary thyroid cancer into molecular subtypes to guide treatment decisions and predict recurrence risk. The company leverages machine learning and genomic data to create clinically actionable tests that help oncologists select appropriate treatments, improving patient outcomes and reducing unnecessary toxic therapies. Qualisure's approach is backed by over 25 years of research and clinical experience, with a focus on innovation, patient-centered care, and collaboration. Their tests are designed to be accessible and scalable, supporting precision medicine as a standard of care in oncology.